Register information Patent

DE file number : 60 2015 045 552.5 (Status: pending/in force, Query started: June 27, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2015 045 552.5
96EP file numberEAKZ15 70 3438.0
86WO file numberWAKZPCT/US2015/014199
97EP publication numberEPN3102604
87WO publication numberWPN2015119923
54Designation/titleTIKOMBINATION EINES PD-1-ANTAGONISTEN UND EINES 4-1BB-AGONISTEN ZUR BEHANDLUNG VON KREBS
51IPC main classICM
(ICMV)
C07K 16/28 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61P 35/00 (2006.01), A61K 39/35 (2006.01)
22DE application dateDATFeb 3, 2015
96EP application dateEATFeb 3, 2015
86WO application dateWATFeb 3, 2015
43Date of first publicationOTAug 13, 2015
Date of publication of grantPETJan 15, 2020
71/73Applicant/ownerINHMerck Sharp & Dohme LLC, Rahway, NJ, US; Pfizer Inc., New York, NY, US
72InventorINDAVIS, Craig, Bennett, Groton, CT 06340, US; KOEHLER, Maria, Theresa, Narberth, PA 19072, US; YAN, Li, North Wales, PA 19454, US
74RepresentativeVTRHornig, Julia, Ph.D. M.Sc. H.B. Sc. (Univ. of Toronto), 80333 München, DE
Address for service GJE INTELLECTUAL PROPERTY, 80333 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201461935748 P
Feb 4, 2014
Due dateFT
FG
Feb 28, 2026
Annual fee for the 12th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003102604A1
Searchable text: EP000003102604A1
Original document: EP000003102604B1
Searchable text: EP000003102604B1
Original document: WO002015119923
Searchable text: WO002015119923
43Date of first publicationEVTAug 13, 2015
Date of the first transfer into DPMAregisterEREGTDec 15, 2016
Date of the (most recent) update in DPMAregisterREGTDec 18, 2024
(Show all update days)(Hide all update days)
  • Dec 18, 2024
    • Due date: changed
    • Procedures: Procedure relating to PCT application, Publication of PCT application, 13.08.2015: deleted
  • Dec 16, 2023; Aug 24, 2023; Jul 18, 2023; Jun 30, 2023; Jun 14, 2023; Dec 15, 2022; Dec 11, 2021; Jan 29, 2021; Jan 8, 2021; Dec 3, 2020; Apr 17, 2020; Mar 20, 2020; Feb 13, 2020; Jan 3, 2020; Jan 2, 2020; Dec 19, 2019; Aug 23, 2019; Aug 1, 2019; Jul 6, 2017
    • Historical data not available for this/these date(s)
  • Dec 15, 2016
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Aug 13, 2015  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Dec 14, 2016  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Jan 26, 2017 Jan 26, 2017 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jan 15, 2020  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Feb 13, 2020 Feb 13, 2020 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Oct 16, 2020 Jan 7, 2021 Details anzeigen
7 New applicant/owner details New applicant/owner details Jul 17, 2023 Aug 24, 2023 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTAug 13, 2015
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTDec 14, 2016
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTJan 26, 2017
Issue numberHN4
YearPJ2017
Publication dateVTJan 26, 2017
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJan 15, 2020
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTFeb 13, 2020
Issue numberHN7
YearPJ2020
Publication dateVTFeb 13, 2020
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTOct 16, 2020
Issue numberHN1
YearPJ2021
Publication dateVTJan 7, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTJan 8, 2021
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 17, 2023
Issue numberHN34
YearPJ2023
Publication dateVTAug 24, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHMerck Sharp & Dohme LLC, Rahway, NJ, US; Pfizer Inc., New York, NY, US
71/73Previous applicant/ownerINHFMerck Sharp & Dohme Corp., Rahway, N.J., US, Pfizer Inc., New York, N.Y., US
Date of update of the procedureREGTAug 24, 2023